HKSE •
Healthcare •
Biotechnology •
Quote as of 09/14/2026 16:08
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeHKSE
Market Capitalization4,794.75 mln
Float409 mln
Earnings Date03/24/2027
EPS
0.77
Decent
P / E
7.77
Undervalued
Piotroski F-Score
2
/ 9
Weak
Beneish M-Score
-1.29
Manipulation likely
1-Year Forecast
9.81
Transformational upside
Relative Strength
33
/ 100
Underperforming
Business Description
Founded in Beijing in 2015, Jacobio Pharmaceuticals is a China-based drug discovery company focused entirely on developing new cancer treatments. The company has built a broad pipeline of experimental therapies targeting some of the most difficult-to-treat cancers, including lung, pancreatic, and colorectal tumors, with several candidates already in advanced clinical trials. Jacobio also works alongside Merck to explore combination treatment approaches, strengthening its position as a serious player in the global oncology space.
